Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.
Wemmert S, Ketter R, Rahnenführer J, Beerenwinkel N, Strowitzki M, Feiden W, Hartmann C, Lengauer T, Stockhammer F, Zang KD, Meese E, Steudel WI, von Deimling A, Urbschat S.
Wemmert S, et al. Among authors: ketter r.
Neoplasia. 2005 Oct;7(10):883-93. doi: 10.1593/neo.05307.
Neoplasia. 2005.
PMID: 16242071
Free PMC article.